Perioperative glucocorticoid administration for prevention of systemic organ failure in patients undergoing esophageal resection for esophageal carcinoma
Keywords:
Esophagectomy, Methylprednisolon, Multiple organ failure, Review literature, Meta-analysisAbstract
CONTEXT AND OBJECTIVE: Preoperative glu- cocorticoid administration has been proposed for reducing postoperative morbidity. This is not widely used before esophageal resection because of incomplete knowledge regarding its effectiveness. The aim here was to assess the effects of preoperative glucocorticoid administra- tion in adults undergoing esophageal resection for esophageal carcinoma. SEARCH STRATEGY: Studies were identified by searching the Cochrane Controlled Trials Reg- ister, MEDLINE, EMBASE, Cancer Lit, SCIELO and Cochrane Library, and by manual searching from relevant articles. The last search for clinical trials for this systematic review was performed in December 2004. SELECTION CRITERIA: This review included randomized studies of patients with potentially resectable carcinomas of the esophagus that compared preoperative glucocorticoid adminis- tration with placebo. DATA COLLECTION AND ANALYSIS: Data were extracted by the same reviewers, and the trial quality was assessed using Jadad scoring. Relative risk and weighted mean difference with 95% confidence limits were used to assess the significance of the difference between the treatment arms. RESULTS: Four randomized trials involving 146 patients were found. There were no dif- ferences in postoperative mortality, sepsis, anastomotic leakage, hepatic and renal failure between the glucocorticoid and placebo groups. There were fewer postoperative respiratory complications (p = 0.005) and multiple post- operative complications (p = 0.004) and lower postoperative plasma interleukin-6 levels (p = 0.00001) with preoperative glucocorticoid ad- ministration. There was a higher postoperative PaO2/FiO2 ratio (p = 0.0001) with preoperative glucocorticoid administration. CONCLUSION: Prophylactic administration of glucocorticoids is associated with decreased postoperative complications.
Downloads
References
Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implica- tions. J Am Coll Surg. 2002;195(5):694-712.
Takeda S, Ogawa R, Nakanishi K, et al. The effect of preoperative high dose methylprednisolone in attenuating the metabolic response after oesphageal resection. Eur J Surg. 1997;163(7):511-7.
Takeda S, Kim, C, Ikezaki H, et al. Preoperative administration of methylprednisolone attenuates cytokine-induced respira- tory failure after esophageal resection. J Nippon Med Sch. 2003;70(1):16-20.
Raimondi AM. Esofagite no coto esofágico em pacientes submetidos à esofagogastroplastia para tratamento do mega- esôfago avançado: avaliação clínica e endoscópica a longo prazo. [Esophagitis in the esophageal stump in patients with advanced achalasia and underwent gastric transposition: a long standing clinical and endoscopic appraisal] [dissertation]. São Paulo: Faculdade de Medicina da Universidade de São Paulo; 2001.
Cecconello I, Rocha JRM, Raimondi AM, Oliveira MA, Gama-Rodrigues JJ. Reflux esophagitis and ectopic columnar epithelium in the esophageal stump after cervical gastroplasty: a reappraisal based on 17 years follow-up [abstract]. Gut. 2001;49(Suppl 3)3028.
McCulloch P, Ward J, Tekkis PP, ASCOT group of surgeons, British Oesophago-Gastric Cancer Group. Mortality and morbidity in gastro-oesophageal cancer surgery: initial re- sults of ASCOT muticentre propective cohort study. BMJ. 2003;327(7425):1192-7.
Rentz J, Bull D, Harpole D, et al. Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients. J Thorac Cardiovasc Surg. 2003;125(5):1114-20.
Meduri GU, Tolley EA, Chrousos GP, Stentz F. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med. 2002;165(7):983-91.
Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003:348(8): 727-34.
Matsutani T, Onda M, Sasajima K, Miyashita M. Glucocorti- coid attenuates a decrease of antithrombin III following major surgery. J Surg Res. 1998;79(2):158-63.
Sato N, Koeda K, Ikeda K, et al. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg. 2002;236(2):184-90.
Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12.
Clarke M, Oxman AD, editors. Cochrane reviewers’ handbook 4.1.6. [updated January 2003]. In: The Cochrane Library. The Cochrane Collaboration. Oxford: Update Software; 2003.
Review Manager (RevMan) [Computer program] Version 4.2.2 for Windows. Oxford, England: The Cochrane Collaboration; 2004. CD-ROM and Internet.
Stubbs SS. Corticosteroids and bioavailability. Transplant Proc. 1975;7(1):11-9.
Fisher LE, Ludwig EA, Wald JA, Sloan RR, Middleton E Jr, Jusko WJ. Pharmacokinetics and pharmacodynamics of meth- ylprednisolone when administered at 8 am versus 4 pm. Clin Pharmacol Ther. 1992;51(6):677-88.
Greos LS, Vichyanond P, Bloedow DC, et al. Methylpred- nisolone achieves greater concentrations in the lung than prednisolone. A pharmacokinetic analysis. Am Rev Respir Dis. 1991;144(3 Pt 1):586-92.
Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003:349(22):2117-27.
